Clinical Trial Update: Allopregnanolone and Dynamic GABA-A Receptor Plasticity in Selective Serotonin Reuptake Inhibitor Responsive Premenstrual Dysphoric Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating allopregnanolone and dynamic GABA-A receptor plasticity in SSRI-responsive Premenstrual Dysphoric Disorder, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder

Drugs mentioned

• Allopregnanolone (allopregnanolone)

Snippet

Sponsor: Johns Hopkins University | Conditions: Premenstrual Dysphoric Disorder (PMDD) | Phase 4 | Status: RECRUITING